Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Kruger

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|November 4, 2000
TNP-470: an angiogenesis inhibitor in clinical development for cancerE A Kruger, W D Figg
Cancer Chemotherapy and Pharmacology|June 5, 1999
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cellsS C Dixon, E A Kruger, K S Bauer, et al.
Invasion & Metastasis|January 21, 2000
UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic responseE A Kruger, M V Blagosklonny, S C Dixon, et al.
Seminars in Oncology|December 12, 2001
Approaches to preclinical screening of antiangiogenic agentsE A Kruger, P H Duray, D K Price, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathwayK S Bauer, K J Cude, S C Dixon, et al.
Seminars in Oncology|October 31, 2001
A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancerW D Figg, P Arlen, J Gulley, et al.
The Journal of Surgical Research|May 19, 2000
The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healingA C Berger, A L Feldman, M F Gnant, et al.
Muscle & Nerve|July 6, 2001
Thalidomide neuropathy in patients treated for metastatic prostate cancerF M Molloy, M K Floeter, N A Syed, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assayE A Kruger, P H Duray, M G Tsokos, et al.
Biotechniques|September 20, 2002
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assayT G Zogakis, N G Costouros, E A Kruger, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|November 4, 2000
TNP-470: an angiogenesis inhibitor in clinical development for cancerE A Kruger, W D Figg
Cancer Chemotherapy and Pharmacology|June 5, 1999
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cellsS C Dixon, E A Kruger, K S Bauer, et al.
Invasion & Metastasis|January 21, 2000
UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic responseE A Kruger, M V Blagosklonny, S C Dixon, et al.
Seminars in Oncology|December 12, 2001
Approaches to preclinical screening of antiangiogenic agentsE A Kruger, P H Duray, D K Price, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathwayK S Bauer, K J Cude, S C Dixon, et al.
Seminars in Oncology|October 31, 2001
A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancerW D Figg, P Arlen, J Gulley, et al.
The Journal of Surgical Research|May 19, 2000
The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healingA C Berger, A L Feldman, M F Gnant, et al.
Muscle & Nerve|July 6, 2001
Thalidomide neuropathy in patients treated for metastatic prostate cancerF M Molloy, M K Floeter, N A Syed, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assayE A Kruger, P H Duray, M G Tsokos, et al.
Biotechniques|September 20, 2002
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assayT G Zogakis, N G Costouros, E A Kruger, et al.
Pageof 1